Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-001880
Filing Date
2025-01-13
Accepted
2025-01-13 09:20:46
Documents
72
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1475229
2 ex31-1.htm EX-31.1 18782
3 ex31-2.htm EX-31.2 18784
4 ex32-1.htm EX-32.1 8276
5 ex32-2.htm EX-32.2 8256
  Complete submission text file 0001493152-25-001880.txt   8022159

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ocea-20240930.xsd EX-101.SCH 63642
7 XBRL CALCULATION FILE ocea-20240930_cal.xml EX-101.CAL 52310
8 XBRL DEFINITION FILE ocea-20240930_def.xml EX-101.DEF 349308
9 XBRL LABEL FILE ocea-20240930_lab.xml EX-101.LAB 449541
10 XBRL PRESENTATION FILE ocea-20240930_pre.xml EX-101.PRE 396905
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1344929
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40793 | Film No.: 25525084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)